SinoMab BioScience Limited (3681.HK) HKSE

1.52

+0(+0.00%)

Updated at December 05 11:32AM

Currency In HKD

Valuation

Market Cap1.1B
Enterprise Value1.52B
P/E Ratio-10.49
PEG Ratio-0.45
Price/Sales Ratio-409.74
Price/Book Ratio6.23
Enterprise/Revenue-485.47
Enterprise/EBITDA-16.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin35.6
Operating Margin32.99

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.66

Income Statement

Revenue2.03M
Revenue/Share-0
Gross Profit543,000
EBITDA-142.79M
Net Income-185.14M
Diluted EPS-0.17

Balance Sheet

Total Cash143.1M
Total Cash/Share0.09
Total Debt408.11M
Total Debt/Equity1.68
Current Ratio0.87
Book Value Per Share0.22

Price History

52-Week Change34.51
52-Week High3.76
52-Week Low0.8
Moving Average 50 Days1.68
Moving Average 200 Days1.85

Statistics

Average Volume8.94M
Shares Outstanding1.2B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A